Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine. [electronic resource]
Producer: 20091222Description: 1071-8 p. digitalISSN:- 1521-0103
- Angiostatins -- antagonists & inhibitors
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Blotting, Western
- Colitis, Ulcerative -- drug therapy
- Colon -- blood supply
- Electrophoresis, Polyacrylamide Gel
- Endostatins -- antagonists & inhibitors
- Enzyme-Linked Immunosorbent Assay
- Female
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- Mesalamine -- administration & dosage
- Neovascularization, Physiologic -- drug effects
- Rats
- Rats, Sprague-Dawley
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.